臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)

???ui.leftmenu.abouttair???
	???ui.leftmenu.explanation???

???ui.leftmenu.bartitle???
	Repositories
	Author
	Title
	Date
	???ui.leftmenu.statisticschart???
	???ui.leftmenu.realtimefacts???
	???ui.leftmenu.trend???

???index.news???
	2019臺灣學術機構典藏研討會
	機構典藏系統RC7版本已發佈

???ui.leftmenu.copyrighttitle???
	???ui.leftmenu.copyrightpublisher???
	???ui.leftmenu.copyrightconference???

???ui.leftmenu.link???
	機構典藏計畫網站
	ROAR
	OpenDOAR
	SHERPA
	OAIster
	JAIRO
	Ira
	DSPACE
	RWWR
	臺大學術典藏NTU Scholars

"hsu c h"???jsp.browse.items-by-author.description???

???jsp.browse.items-by-author.back???
???jsp.browse.items-by-author.order1???	???jsp.browse.items-by-author.order2???

Showing items 26-50 of 1656 (67 Page(s) Totally)
<< < 1 2 3 4 5 6 7 8 9 10 > >>
View [10|25|50] records per page

Institution	Date	Title	Author
臺大學術典藏	2022-09-15T01:09:56Z	Weekly cisplatin plus infusional high-dose 5-fluorouracil and leucovorin (P-HDFL) for metastatic urothelial carcinoma: An effective regimen with low toxicity	Chia-Chi Lin; Hsu C.-H.; Huang C.-Y.; Cheng A.-L.; Chen J.; Vogelzang N.J.; Pu Y.-S.
臺大學術典藏	2022-09-15T01:09:56Z	Phase II Trial of Weekly Paclitaxel, Cisplatin Plus Infusional High Dose 5-Fluorouracil and Leucovorin for Metastatic Urothelial Carcinoma	Chia-Chi Lin; Hsu C.-H.; Huang C.-Y.; Cheng A.-L.; Vogelzang N.J.; Pu Y.-S.
臺大學術典藏	2022-09-15T01:09:56Z	Complete response of urothelial carcinoma to chemotherapy in renal allograft recipients: A two-case study	Chia-Chi Lin; Hsu C.-H.; Pu Y.-S.
臺大學術典藏	2022-09-15T01:09:55Z	Concurrent chemoradiotherapy with twice weekly paclitaxel and cisplatin followed by esophagectomy for locally advanced esophageal cancer	Chia-Chi Lin; Hsu C.-H.; Cheng J.C.; Wang H.-P.; Lee J.-M.; Yeh K.-H.; Yang C.-H.; Lin J.-T.; Cheng A.-L.; Lee Y.-C.
臺大學術典藏	2022-09-15T01:09:55Z	A phase II trial of weekly paclitaxel and high-dose 5-fluorouracil plus leucovorin in patients with chemotherapy-pretreated metastatic breast cancer	Chia-Chi Lin; Cheng A.-L.; Hsu C.-H.; Lu Y.-S.; Hsu C.; Yeh K.-H.; Wu C.-Y.; Huang C.-S.; Yang C.-H.
臺大學術典藏	2022-09-15T01:09:54Z	Arsenic trioxide in patients with hepatocellular carcinoma: A phase II trial	Chia-Chi Lin; Hsu C.; Hsu C.-H.; Hsu W.-L.; Cheng A.-L.; Yang C.-H.
臺大學術典藏	2022-09-15T01:09:54Z	Gemcitabine and ifosfamide as a second-line treatment for cisplatin-refractory metastatic urothelial carcinoma: A phase II study	Chia-Chi Lin; Hsu C.-H.; Huang C.-Y.; Keng H.-Y.; Tsai Y.-C.; Huang K.-H.; Cheng A.-L.; Pu Y.-S.
臺大學術典藏	2022-09-15T01:09:54Z	Prognostic Factors for Metastatic Urothelial Carcinoma Treated with Cisplatin and 5-Fluorouracil-Based Regimens	Chia-Chi Lin; Hsu C.-H.; Huang C.-Y.; Tsai Y.-C.; Huang K.-H.; Cheng A.-L.; Pu Y.-S.
臺大學術典藏	2022-09-15T01:09:53Z	Weekly paclitaxel and high-dose 5-fluorouracil plus leucovorin in hormone-refractory prostate cancer: In vitro combined effects and a Phase II trial	Chia-Chi Lin; Hsu C.-H.; Hour T.-C.; Cheng A.-L.; Huang C.-Y.; Huang K.-H.; Chen J.; Pu Y.-S.
臺大學術典藏	2022-09-15T01:09:53Z	Multifractionated paclitaxel and cisplatin combined with 5-fluorouracil and leucovorin in patients with metastatic or recurrent esophageal squamous cell carcinoma	Chia-Chi Lin; Yeh K.-H.; Yang C.-H.; Hsu C.; Tsai Y.-C.; Hsu W.-L.; Cheng A.-L.; Hsu C.-H.
臺大學術典藏	2022-09-15T01:09:52Z	Outcome of advanced nonsmall cell lung cancer patients receiving gemcitabine and weekly paclitaxel as first-line treatment	Lin Z.-Z.; Hsu C.; Chang Y.-C.; Yu C.-J.; Hsu C.-H.; Chia-Chi Lin; Cheng A.-L.; Yang P.-C.; Yang C.-H.
臺大學術典藏	2022-09-15T01:09:52Z	Systemic therapy for metastatic urothelial carcinoma	Chia-Chi Lin; Hsu C.-H.; Pu Y.-S.; Vogelzang N.J.
臺大學術典藏	2022-09-15T01:09:51Z	Acute encephalopathy following arsenic trioxide for metastatic urothelial carcinoma	Chia-Chi Lin; Pu Y.-S.; Hsu C.-H.; Keng H.-Y.; Cheng A.-L.; Yang C.-H.
臺大學術典藏	2022-09-15T01:09:51Z	Improved local control by surgery and paclitaxel-based chemoradiation for esophageal squamous cell carcinoma: Results of a retrospective non-randomized study	Hsu F.-M.; Chia-Chi Lin; Lee J.-M.; Chang Y.-L.; Hsu C.-H.; Tsai Y.-C.; Lee Y.-C.; Cheng J.C.-H.
臺大學術典藏	2022-09-15T01:09:06Z	Neutrophil-to-lymphocyte Ratio and Use of Antibiotics Associated With Prognosis in Esophageal Squamous Cell Carcinoma Patients Receiving Immune Checkpoint Inhibitors	Guo J.-C.; Chia-Chi Lin; Lin C.-Y.; Hsieh M.-S.; Kuo H.-Y.; Lien M.-Y.; Shao Y.-Y.; Huang T.-C.; Hsu C.-H.
臺大學術典藏	2022-09-15T01:09:01Z	A phase I study of pexidartinib, a colony-stimulating factor 1 receptor inhibitor, in Asian patients with advanced solid tumors	Lee J.-H.; Chen T.W.-W.; Hsu C.-H.; Yen Y.-H.; Yang J.C.-H.; Cheng A.-L.; Sasaki S.-I.; Chiu L.Y.; Sugihara M.; Ishizuka T.; Oguma T.; Tajima N.; Chia-Chi Lin
臺大學術典藏	2022-09-15T01:08:57Z	Two first-in-human studies of xentuzumab, a humanised insulin-like growth factor (IGF)-neutralising antibody, in patients with advanced solid tumours	de Bono J.; Chia-Chi Lin; Chen L.-T.; Corral J.; Michalarea V.; Rihawi K.; Ong M.; Lee J.-H.; Hsu C.-H.; Yang J.C.-H.; Shiah H.-S.; Yen C.-J.; Anthoney A.; Jove M.; Buschke S.; Fuertig R.; Schmid U.; Goeldner R.-G.; Strelkowa N.; Huang D.C.-L.; Bogenrieder T.; Twelves C.; Cheng A.-L.
臺大學術典藏	2022-09-15T01:08:47Z	Response to Immune Checkpoint Inhibitors in Recurrent or Metastatic Esophageal Squamous Cell Carcinoma May Be Affected by Tumor Sites	Guo J.-C.; Lin C.-Y.; Chia-Chi Lin; Huang T.-C.; Lien M.-Y.; Lu L.-C.; Kuo H.-Y.; Hsu C.-H.
臺大學術典藏	2022-09-15T01:08:43Z	Prognostic value of PD-L1 expression on immune cells or tumor cells for locally advanced esophageal squamous cell carcinoma in patients treated with neoadjuvant chemoradiotherapy	Huang T.-C.; Liang C.-W.; Li Y.-I.; Guo J.-C.; Chia-Chi Lin; Chen Y.-J.; Cheng A.-L.; Hsu C.-H.
臺大學術典藏	2022-09-14T01:29:23Z	Limited predictive or prognostic role of tumor-infiltrating tissue-resident memory cd8 t cells in patients with hepatocellular carcinoma receiving immunotherapy	Shen Y.-C.; Yeh C.-P.; Jeng Y.-M.; Hsu C.; Hsu C.-H.; Lin Z.-Z.; Shao Y.-Y.; Lu L.-C.; Liu T.-H.; CHIEN-HUNG CHEN; Cheng A.-L.
臺大學術典藏	2022-09-13T08:19:08Z	TSOC-HFrEF registry: A registry of hospitalized patients with decompensated systolic heart failure: Description of population and management	Wang C.-C.; Chang H.-Y.; Yin W.-H.; Wu Y.-W.; Chu P.-H.; CHIH-CHENG WU; Hsu C.-H.; Wen M.-S.; Voon W.-C.; Lin W.-S.; Huang J.-L.; Chen S.-M.; Yang N.-I.; Chang H.-C.; Chang K.-C.; Sung S.-H.; Shyu K.-G.; Lin J.-L.; Mar G.-Y.; Chan K.-C.; Kuo J.-Y.; Wang J.-H.; Chen Z.-C.; Tseng W.-K.; Cherng W.-J.
臺大學術典藏	2022-09-13T08:19:07Z	The Obesity-Mortality Paradox in Patients With Heart Failure in Taiwan and a Collaborative Meta-Analysis for East Asian Patients	Lin G.-M.; Li Y.-H.; Yin W.-H.; Wu Y.-W.; Chu P.-H.; CHIH-CHENG WU; Hsu C.-H.; Wen M.-S.; Voon W.-C.; Wang C.-C.; Yeh S.-J.; Lin W.-S.; Chan K.-C.; Chang H.-C.; Chang K.-C.; Chen Z.-C.; Chen S.-M.; Chu P.-H.; Hsu C.-H.; Huang J.-L.; Kuo J.Y.; Lin J.-L.; Lin W.-S.; Mar G.-Y.; Shyu K.-G.; Sung S.-H.; Tseng W.-K.; Voon W.-C.; Wang J.-H.; Wen M.-S.; Yang N.-I.
臺大學術典藏	2022-09-13T08:19:05Z	One-year outcomes of acute decompensated systolic heart failure in Taiwan: Lessons from TSOC-HFreF registry	Chang H.-Y.; Wang C.-C.; Wu Y.-W.; Chu P.-H.; CHIH-CHENG WU; Hsu C.-H.; Wen M.-S.; Voon W.-C.; Lin W.-S.; Huang J.-L.; Chen S.-M.; Yang N.-I.; Chang H.-C.; Chang K.-C.; Sung S.-H.; Shyu K.-G.; Lin J.-L.; Mar G.-Y.; Chan K.-C.; Kuo J.-Y.; Wang J.-H.; Chen Z.-C.; Tseng W.-K.; Cherng W.-J.; Yin W.-H.
臺大學術典藏	2022-09-07T06:50:50Z	Esophageal adenocarcinoma arising from Barrett's epithelium in Taiwan	Tu C.-H.; Lee C.-T.; Perng D.-S.; Chang C.-C.; Hsu C.-H.; YI-CHIA LEE
臺大學術典藏	2022-09-06T08:56:53Z	Phase I clinical trial of curcumin, a chemopreventive agent, in patients with high-risk or pre-malignant lesions	Chen A.-L.; Hsu C.-H.; Lin J.-K.; Hsu M.-M.; Ho Y.-F.; She T.-S.; Ko J.-Y.; Lin J.-T.; Lin B.-R.; MING-SHIANG WU; Yu H.-S.; Jee S.-H.; Chen G.-S.; Chen T.-M.; Chen C.-A.; Lai M.-K.; Pu Y.-S.; Pan M.-H.; Wang Y.-J.; Tsai C.-C.; Hsieh C.-Y.

Showing items 26-50 of 1656 (67 Page(s) Totally)
<< < 1 2 3 4 5 6 7 8 9 10 > >>
View [10|25|50] records per page

	English \| 正體中文 \| 简体中文 \| 2818629
	???header.visitor??? : 28122196 ???header.onlineuser??? : 141 ???header.sponsordeclaration???